CSLLY News and Press, CSL Ltd ADR From 05/15/23

2023-05-15 08:26:38 ET Dutch biotech uniQure N.V. ( NASDAQ: QURE ) added ~7% pre-market Monday after announcing an agreement to sell a portion of royalty rights expected to receive from Australian drugmaker CSL Limited ( OTCQX:CSLLY ) in relation to the gene therapy Hemgenix...

2023-05-11 08:21:38 ET Arcturus Therapeutics ( NASDAQ: ARCT ) added ~3% pre-market Thursday after H.C. Wainwright upgraded the biotech to Buy from Neutral, raising its price target to $51 from $19 per share on the potential of its COVID-19 vaccine ARCT-154. In November, Arct...

Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis Canada NewsWire The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secon...

2023-04-28 08:38:45 ET Summary The Project $1M portfolio continues to grind away, well into its 8th year and is now back above the S&P500 on a cumulative basis once again. Strong performances from Meta and MercadoLibre helped power strong returns in Q1. I made several chan...

New York, United States (ABN Newswire) - OTC Markets Group Inc. (OTCMKTS:OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced CSL Limited (ASX:CSL) (OTCMKTS:CSLLY), a leading global biotechnology company with a dynamic portfolio of lifesaving medicine...

NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced CSL Limited (ASX: CSL; OTCQX: CSLLY), a leading global biotechnology company with a dynamic portfolio of lifesavin...

CSL Seqirus Proud to Attend and Present at 2023 Canadian Immunization Conference Canada NewsWire Experts and public health leaders gather at annual conference in Ottawa to discuss the importance and future of immunization in Canada MONTREAL , April 25...

2023-04-19 05:38:55 ET CSL Behring said on Tuesday that the U.S. Food and Drug Administration (FDA) approved a 50mL/10gm prefilled syringe for Hizentra (Immune Globulin Subcutaneous [Human] 20% Liquid). CSL Behring, a unit of Australia's CSL ( OTCPK:CSLLY ) ( OTCPK:CMXHF ...

CSL Behring Receives FDA Approval for Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) 50mL Prefilled Syringe PR Newswire Hizentra ® is the first and only immune globulin (Ig) available in prefilled syringes, offering those living with Primary Immunode...

2023-04-12 10:50:20 ET Summary CSL Limited is one of the largest global biotechnology companies globally that specializes in the research, development, and manufacturing of plasma-based therapies, vaccines, and other pharmaceutical products. The combination of long-term revenue re...